From: Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy
Brain ID | Age | Gender | PMI (h) | MSA-P/MSA-C | Disease duration (y) |
---|---|---|---|---|---|
MSA | |||||
MSA1 | 61 | male | 21 | MSA-P | 4 |
MSA2 | 82 | male | 8 | MSA-P | 7 |
MSA3 | 64 | male | 22 | MSA-P | 8 |
MSA4 | 61 | male | 7 | MSA-P | 2 |
MSA5 | 62 | male | 31 | MSA-C | 10 |
MSA6 | 71 | female | 19 | MSA-P | 6 |
MSA7 | 74 | male | 16 | MSA-P | 10 |
MSA8 | 67 | male | 11 | MSA-P | 8 |
Control | |||||
Con1 | 78 | female | 37 | N/A | N/A |
Con2 | 82 | female | 7.5 | N/A | N/A |
Con3 | 69 | male | 13.5 | N/A | N/A |
Con4 | 85 | male | 9 | N/A | N/A |
Con5 | 65 | male | 14.5 | N/A | N/A |
Con6 | 68 | male | 45.5 | N/A | N/A |
Con7 | 73 | male | 38.5 | N/A | N/A |
Con8 | 88 | male | 9 | N/A | N/A |
Con9 | 85 | female | 10 | N/A | N/A |
Con10 | 81 | male | 29 | N/A | N/A |